Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Hadrien Mendonca of IIFL suggests buying SBI with a target Rs 315.
We recommend buying this stock at current levels for a target of Rs 2,855 over the next one month, and a stop loss should be fixed at Rs 2,405.
Investors are advised to remain cautious and watch out for two levels: 10,770 on the upside and 10,550 on the down.
At this juncture, markets are clearly experiencing their corrective phases (price wise as well as time-wise) and hence, one should not venture into it aggressively.
Mitessh Thakkar of mitesshthakkar.com recommends buying Bajaj Finance with a stop loss of Rs 2099 and target of Rs 2160 and Indian Oil Corporation with a stop loss of Rs 166 and target of Rs 180.
We expect the Nifty to form a higher base by consolidating in a broader range of 10,400–10,850 that would pave the way for the next leg of the upmove.
"The stock can be bought at current level and on dips to Rs 2,400 with a stop loss below Rs 2,350 and target of Rs 2,800 levels," says Ashish Chaturmohta of Sanctum Wealth Management.
"The immediate resistance for the Nifty is placed at 10,735. If the index crosses above this level then the next target is seen at 10,800-10830," says Ashish Chaturmohta of Sanctum Wealth Management.
"We expect the Nifty to consolidate within a broader range of 10,300–10,600 amid stock specific action as we are going through the Q4 earnings season," says Dharmesh Shah of ICICI Direct.com.
The stock has major support in the range of Rs 2,150-2,200 being the confluence of 80% retracement of the previous up move from Rs 2,050 to Rs 2,549 and 12 months EMA, says Dharmesh Shah of ICICI Direct.com Research.
Here is a list of top three stocks that could deliver up to 21% return in the next six months.
Dharmesh Shah of ICICI Direct.com Research is of the view that one may buy Pfizer with a target of Rs 2960.
Divis Laboratories, Crompton Greaves Consumer Electricals, Indian Hotels, Pfizer and Bombay Dyeing could give up to 16% return in the short term
Broadly post the recent fall in the market, the index is likely to trade in a range of 10,740-10,400 and consolidate around these levels.
Ruchit Jain of Angel Broking is of the view that one may buy NIIT Technologies with a target of Rs 681.
Rising liquidity in domestic MFs is one of the biggest factors in driving rally on D-Street which is trading at record highs.
Gaurang Shah of Geojit BNP Paribas is of the view that one may prefer Aurobindo Pharma.
SP Tulsian of sptulsian.com tells CNBC-TV18 why he would not give a buy call on MRF stock which touched Rs 50,000-mark in trade Wednesday. He also shares his take on other tyre stocks.
Shahina Mukadam, Independent Market Expert advises holding Pfizer.
CNBC-TV18's analysts give you stocks to keep on your radar for trade today: The stocks that are likely to be under pressure are Lupin, Chambal Fertiliser, Tree House Education, United Breweries and Bajaj Auto while the stocks that are likely to gain are Wipro, Pfizer, Spicejet, Eveready, Indian Hume, Tata Motors and Tech Mahindra.
According to Sudarshan Sukhani of s2analytics.com, Century Textiles is a positional short and recommends buying Lakshmi Machine Works.
SP Tulsian of sptulsian.com is of the view that Vivimed Labs may test Rs 500 in next six months.
Sudarshan Sukhani of s2analytics.com recommends buying Pfizer.
Here's a list of top 10 stocks that are in news today due to fourth quarter earnings, entry into F&O segment and merger deals.
Vishal Malkan of malkansview.com is of the view that one can hold Pfizer for long term.